External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 9, 2013, Pages 1201-1204

  Koehler, Edith M ^a   Schouten, Jeoffrey N L ^a   Hansen, Bettina E ^a   Hofman, Albert ^a   Stricker, Bruno H ^a   Janssen, Harry L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Lipid Accumulation Product; Obesity; The Netherlands

Indexed keywords

AMIODARONE; CORTICOSTEROID; GAMMA GLUTAMYLTRANSFERASE; METHOTREXATE; TAMOXIFEN; TRIACYLGLYCEROL;

ABDOMINAL RADIOGRAPHY; AGED; ALGORITHM; ANTHROPOMETRY; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; BODY MASS; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; ECHOGRAPHY; EUROPEAN AMERICAN; EXTERNAL VALIDITY; FATTY LIVER; FATTY LIVER INDEX; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEMI STRUCTURED INTERVIEW; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AREA UNDER THE RECEIVER OPERATOR CHARACTERISTIC; AUROC; CI; CONFIDENCE INTERVAL; EPIDEMIOLOGY; FATTY LIVER INDEX; FLI; HOMA-IR; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; LAP; LIPID ACCUMULATION PRODUCT; NAFLD; NONALCOHOLIC FATTY LIVER DISEASE; OBESITY; THE NETHERLANDS;

AGED; AGED, 80 AND OVER; ALGORITHMS; BODY MASS INDEX; CLINICAL MEDICINE; COHORT STUDIES; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; MALE; ROC CURVE; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84882845563     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.12.031     Document Type: Article

References (19)

1. Charlton M.R., Burns J.M., Pedersen R.A., et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011, 141:1249-1253.
2. Ong J.P., Pitts A., Younossi Z.M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008, 49:608-612.
3. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
4. Rafiq N., Bai C., Fang Y., et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009, 7:234-238.
5. Lazo M., Hernaez R., Bonekamp S., et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011, 343:d6891.
6. Ruhl C.E., Everhart J.E. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009, 136:477-485.
7. Lee T.H., Kim W.R., Benson J.T., et al. Serum aminotransferase activity and mortality risk in a United States community. Hepatology 2008, 47:880-887.
8. Bedogni G., Bellentani S., Miglioli L., et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006, 6:33.
9. Hofman A., van Duijn C.M., Franco O.H., et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011, 26:657-686.
10. Hamaguchi M., Kojima T., Itoh Y., et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007, 102:2708-2715.
11. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
12. Kim J.H., Kwon S.Y., Lee S.W., et al. Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population. Liver Int 2011, 31:1600-1601.
13. Bedogni G., Kahn H.S., Bellentani S., et al. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 2010, 10:98.
14. Kahn H.S. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care 2006, 29:151-153.
15. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
16. Calori G., Lattuada G., Ragogna F., et al. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 2011, 54:145-152.
17. Gastaldelli A., Kozakova M., Højlund K., et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009, 49:1537-1544.
18. Balkau B., Lange C., Vol S., et al. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 2010, 10:56.
19. Koehler E.M., Schouten J.N., Hansen B.E., et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 2012, 57:1305-1311.